drugset / Trial / NCT00978341

Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

NCT00978341

Terminated 15 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindOther

Summary

The study is designed to assess if spinal cord injury patients have reduced pain after taking either pregabalin or placebo in a cross over design. Patients had either pain at the level of their injury or below the level of their injury.

Timeline

Start
2007-02
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg

Indications